Clinical Trial

A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Researchers want to learn about calderasib when given with rosuvastatin and metformin in healthy people. The goal of this study is to compare the amount of rosuvastatin and metformin in a person's body over time when given with and without calderasib
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-10-27; most recent amendment 2026-05-05.
Status change: Active, Not Recruiting → Completed 2026-01-13
Status change: Recruiting → Active, Not Recruiting 2025-12-08
Status change: Not Yet Recruiting → Recruiting 2025-11-25
Trial Details
NCT Number NCT07222098
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 16 participants
Start Date 2025-11-19
Primary Completion 2025-12-14 (estimated)
Study Completion 2025-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-05-06